Tim Thorpe

Tim Thorpe

Board Member

Tim Thorpe holds extensive for-profit and non-profit knowledge and experience. His career history includes for-profit business planning, marketing and advertising with strong strategic, media and communications planning experience. Tim has also built strong non-profit expertise through experiences with various organizations focused on social services, arts, education, youth and the elderly.

When asked why he was passionate about MHIF and wanted to serve on the board, Tim answered, "With the aging of the baby boomers, heart health research and best practices become even more front and center. I've always admired the Minneapolis Heart Institute Foundation for the work they've accomplished and continue to do. I personally have had grandparents, parents - even me - be the beneficiaries of MHIF's research. I look forward to learning how I can support the organization as a board member, but also advocate and contribute to MHIF. I am honored to be part of this great organization."

Back to Board of Directors

Tim Thorpe
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.